We are live on ! Find out more
ELV icon

Elevance Health

1,517 hedge funds and large institutions have $64.3B invested in Elevance Health in 2025 Q3 according to their latest regulatory filings, with 165 funds opening new positions, 534 increasing their positions, 611 reducing their positions, and 227 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more call options, than puts

Call options by funds: $953M | Put options by funds: $837M

0% more funds holding in top 10

Funds holding in top 10: 32 → 32 (0)

2.45% less ownership

Funds ownership: 90.86% → 88.41% (-2.4%)

5% less funds holding

Funds holding: 1,600 → 1,517 (-83)

13% less repeat investments, than reductions

Existing positions increased: 534 | Existing positions reduced: 611

27% less first-time investments, than exits

New positions opened: 165 | Existing positions closed: 227

28% less capital inflows, than outflows

Capital inflows: $5.34B | Capital outflows: $7.41B

Holders
1,517
Holders Change
-83
Holders Change %
-5.19%
% of All Funds
19.79%
Holding in Top 10
32
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.42%
New
165
Increased
534
Reduced
611
Closed
227
Calls
$953​M
Puts
$837​M
Net Calls
+$117​M
Net Calls Change
-⁠$94.6​M

ELV Hedge Fund Activity: Q3 2025 in Review

1,517 of the 7,664 institutional investors tracked by Wall St. Rank reported a position in Elevance Health (ELV) for Q3 2025, worth a combined $64.3B — down 19% from $79.7B a quarter earlier.

Sellers outnumbered buyers: 227 funds closed out of ELV and 165 opened new positions — a net loss of 62 holders — while 611 trimmed existing stakes and 534 added.

The largest buyer was Harris Associates, adding an estimated $281M. The largest seller was Capital International Investors, cutting an estimated $1.1B.

  • 1,517 institutional investors held Elevance Health (ELV) as of Q3 2025, down from 1,600 in Q2 2025.
  • Funds reported $64.3B of Elevance Health stock for Q3 2025, down 19% quarter-over-quarter.
  • 165 funds opened new Elevance Health positions in Q3 2025 and 227 closed out, a net change of -62 holders.
  • The largest Elevance Health buyer in Q3 2025 was Harris Associates, an estimated $281M added.
  • The largest Elevance Health seller in Q3 2025 was Capital International Investors, an estimated $1.1B sold.

Based on aggregated 13F filings for Q3 2025.